First UK real-world study shows promise for sacituzumab govitecan in metastatic breast cancer Post author: Post published:April 26, 2024 Post category:uncategorized The real-world safety and efficacy of sacituzumab govitecan (SG) against metastatic triple-negative breast cancer. You Might Also Like Study links impaired synaptic pruning to autism April 30, 2025 New study identifies regional hotspots for Parkinson’s disease October 30, 2023 How fruit fly genetics could change the fight against mosquito diseases January 25, 2025